This Biotech’s Stock Soaring After FDA Official Exits
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
Learn why young investors should prioritize compounding in their financial strategy. Early investments can yield significant long-term benefits.
28,299 articlesBiotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
The SPDR Russell 1000 Yield Focus ETF nears a $125 price point, anchored by Johnson & Johnson and other blue-chip div...
Capital Group's Dividend Value ETF has significantly outperformed SCHD since February 2022, prompting renewed debate ...
As geopolitical risk stays elevated, investors are reevaluating defense allocations. Lessons from WWII’s most feared ...
Tech stocks are leading the charge, lifting major indices to new highs. This guide breaks down the drivers, the bigge...
As rates stay elevated in mid-2026, investors are turning to senior loan ETFs for income. A $500,000 position in seni...
Investors are pouring into autonomous weapons and defense tech, signaling a shift from software plays to hardware-dri...
In morning trading, Tesla sinks about 5% while Lucid edges higher and Rivian drifts, signaling a diverging path for t...
Warren Buffett behind Berkshire surprised many by boosting a tech giant stake. This article breaks down why Alphabet ...
Oil prices surged to multi-week highs, sending Apple, Tesla, and Alphabet down in after-hours trading while Nasdaq fu...
Block, Palantir, Atlassian, and Salesforce are in the spotlight as layoffs and hiring pauses test how cost cuts affec...
Evaxion's Q1 2026 results shed light on how its AI-driven drug discovery model is translating into collaborations and...